Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013

PURPOSE: The objective of this study was to determine whether the 21-gene Recurrence Score (RS) provides clinically meaningful information in patients with de novo stage IV breast cancer enrolled in the Translational Breast Cancer Research Consortium (TBCRC) 013. PATIENTS AND METHODS: TBCRC 013 was...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Oncol
Autori principali: King, Tari A., Lyman, Jaclyn P., Gonen, Mithat, Voci, Amy, De Brot, Marina, Boafo, Camilla, Sing, Amy Pratt, Hwang, E. Shelley, Alvarado, Michael D., Liu, Minetta C., Boughey, Judy C., McGuire, Kandace P., Van Poznak, Catherine H., Jacobs, Lisa K., Meszoely, Ingrid M., Krontiras, Helen, Babiera, Gildy V., Norton, Larry, Morrow, Monica, Hudis, Clifford A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2016
Soggetti:
ORIGINAL REPORTS
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4981976/
https://ncbi.nlm.nih.gov/pubmed/27001590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.63.1960
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi